Close
ACHEMA MIDDLE EAST 2026

Tag: Europe

AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN

Alexion, an AstraZeneca rare disease, has received EU approval for Koselugo (selumetinib), its oral, selective MEK inhibitor, to treat symptomatic, inoperable plexiform neurofibromas (PN)...

UK Grants Pharma Firms Early Access to Aligned Pathway

Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected. The Medicines and Healthcare products...

ABPI Launches Manifesto to Advance Scottish Pharma Sector

The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...

Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

Swiss pharmaceutical leader Novartis has entered into a cardiovascular drug licensing deal valued at up to $5.2 billion with China-based Argo Biopharmaceutical. The deal...

Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal

Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...

Popular